Daniel LeBlanc

Senior Research Associate
Pfizer Inc.
Cambridge, Massachusetts, United States

Presentation(s):

• PB0187 - Impact of One-Stage Clotting Assay Reagents on Factor XIa Levels and Clotting Time with High Activity Factor IX (R338L) Variant

  Sunday, June 25, 2023
  18:30 – 19:30 ET